Centene Q1 Revenue Rises 7.1% to $49.94B, EPS Beats by $1.24
Centene’s Q1 revenue rose 7.1% to $49.94 billion, $2.4 billion above consensus, and net earnings of $1.54 billion ($3.11 per share) beat expectations by $1.24. Medicaid margin improved through a late-2024 multipronged trend program, aided by a light flu season and weather benefits, with D-SNP now 40% of Medicare.
1. Q1 Earnings Beat and Revenue Growth
Centene reported Q1 revenue of $49.94 billion, up 7.1% year-over-year and $2.4 billion above consensus, driving net earnings of $1.54 billion or $3.11 per share, which surpassed estimates by $1.24.
2. Medicaid Margin Improvement
A multipronged trend management program launched in late 2024 standardized utilization controls and intensified fraud, waste and abuse prevention, contributing significantly to Medicaid margin gains.
3. Marketplace Segment Performance
The Marketplace division met expectations as increased Silver tier utilization was balanced by SG&A cost efficiencies and anticipated risk adjustment receivables.
4. Medicare D-SNP Expansion
Centene aligned Medicare membership with its Medicaid footprint, growing dual-eligible special needs plan (D-SNP) enrollment to 40% of the overall Medicare portfolio, enhancing risk and cost management synergies.